Sanofi, a global healthcare leader, today signed a manufacturing agreement for seven key products with Awamedica. Products cover three key therapeutic areas – diabetes, cardiovascular and oncology. Awamedica is the first pharmaceutical company based in Erbil developing, manufacturing and marketing products adapted to the needs of the Iraqi market.
Awamedica is a Pharmaceutical Manufacturing Company with Swedish Quality and Expertise. Located in Erbil, Iraq.
Awamedica is compliant with current Good Manufacturing Practice (cGMP). We are working together with the Regulatory Authorities to serve people with safe and effective medicines.
The project started 2004 by Prof Bahram Resul, founding CEO of Awamedica, was co-inventor of Xatalan/Latanoprost, a medication used to treat glaucoma, as the head of the Medicinal Chemistry Department of Pharmacia Ophthalmics (now part of Pfizer), a pharmaceuticals firm in Sweden, where he resided for 33 years. Today, Xalatan sales, exceed $2 billion per annum. In 2006 Dr. Resul was approached by Nechirvan Barzani...